↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "(WFRF:(Botker H E)) "

Search: (WFRF:(Botker H E))

Result 1-7 of 7

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Bouyoucef, S E, et al. (author) Poster Session 2 : Monday 4 May 2015, 08 2015 In: European Heart Journal Cardiovascular Imaging. - : Oxford University Press (OUP). - 2047-2404 .- 2047-2412. ; 16 Suppl 1 Journal article (peer-reviewed)
2.	Arora, S., et al. (author) Effect of Everolimus Introduction and Calcineurin Inhibitor Reduction on Graft Vasculopathy in Heart Transplant Recipients 2010 In: Journal of Heart and Lung Transplantation. - : Elsevier BV. - 1557-3117 .- 1053-2498. ; 29:2, Suppl. 1 Conference paper (peer-reviewed)
3.	Arora, S, et al. (author) Effect of Everolimus Introduction and Calcineurin Inhibitor Reduction on Graft Vasculopathy in Heart Transplant Recipients in JOURNAL OF HEART AND LUNG TRANSPLANTATION, vol 29, issue 2, pp S50-S50 2010 In: JOURNAL OF HEART AND LUNG TRANSPLANTATION. - : Elsevier Science B.V., Amsterdam.. ; , s. S50-S50 Conference paper (peer-reviewed)abstract n/a
4.	Arora, S., et al. (author) The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial 2015 In: American Journal of Transplantation. - : Elsevier BV. - 1600-6135. ; 15:7, s. 1967-1975 Journal article (peer-reviewed)abstract Early initiation of everolimus with calcineurin inhibitor therapy has been shown to reduce the progression of cardiac allograft vasculopathy (CAV) in de novo heart transplant recipients. The effect of de novo everolimus therapy and early total elimination of calcineurin inhibitor therapy has, however, not been investigated and is relevant given the morbidity and lack of efficacy of current protocols in preventing CAV. This 12-month multicenter Scandinavian trial randomized 115 de novo heart transplant recipients to everolimus with complete calcineurin inhibitor elimination 7-11 weeks after HTx or standard cyclosporine immunosuppression. Ninety-five (83%) patients had matched intravascular ultrasound examinations at baseline and 12 months. Mean (SD) recipient age was 49.9 +/- 13.1 years. The everolimus group (n=47) demonstrated significantly reduced CAV progression as compared to the calcineurin inhibitor group (n=48) (Maximal Intimal Thickness 0.03 +/- 0.06 and 0.08 +/- 0.12mm, Percent Atheroma Volume 1.3 +/- 2.3 and 4.2 +/- 5.0%, Total Atheroma Volume 1.1 +/- 19.2mm(3) and 13.8 +/- 28.0mm(3) [all p-values0.01]). Everolimus patients also had a significantly greater decline in levels of soluble tumor necrosis factor receptor-1 as compared to the calcineurin inhibitor group (p=0.02). These preliminary results suggest that an everolimus-based CNI-free can potentially be considered in suitable de novo HTx recipients.
5.	Arora, S, et al. (author) Effect of Everolimus Introduction and Calcineurin Inhibitor Reduction on Cardiac Allograft Vasculopathy Assessed by Virtual Histology in JOURNAL OF HEART AND LUNG TRANSPLANTATION, vol 30, issue 4, pp S33-S34 2011 In: JOURNAL OF HEART AND LUNG TRANSPLANTATION. - : ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA. ; , s. S33-S34 Conference paper (peer-reviewed)abstract n/a
6.	Erlinge, D, et al. (author) Therapeutic Hypothermia for the Treatment of Acute Myocardial Infarction - The CHILL-MI Trial 2013 In: CIRCULATION. - 0009-7322. ; 128:24, s. 2720-2720 Conference paper (other academic/artistic)
7.	Gyongyosi, M, et al. (author) NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia: subanalysis of the EUROINJECT-ONE multicenter double-blind randomized study 2005 In: Circulation. - 1524-4539. ; 112:99 Suppl, s. I157-I165 Journal article (peer-reviewed)

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-7 of 7

Refine your search

Type of publication: conference paper (4); journal article (3)

Type of content: peer-reviewed (6); other academic/artistic (1)

Author/Editor: Gullestad, L (4); Engblom, H (2); Costa, G. (1); Robinson, J. (1); Santos, J. (1); Smith, M. (1); show more...; Brünner, S. (1); Robinson, S. (1); Aukrust, P. (1); Li, Q. (1); Soerensen, J. (1); Antoni, Gunnar (1); Sörensen, Jens (1); James, S. (1); Ueland, T (1); Reid, S. (1); Svensson, M. (1); Menendez, D. (1); Takahashi, K (1); Yousefi, B (1); Wikstrom, G. (1); Soares, J (1); Bottcher, M. (1); Fernandez, J. (1); Ruck, A (1); Yla-Herttuala, S (1); Wallentin, L (1); Torres, M. (1); Martinez, C (1); Ferrari, C. (1); Reddy, P (1); Ramos, D (1); Andersson, B. (1); Sylven, C (1); Carlsson, M (1); Lehner, S. (1); Jansson, K. (1); Cheng, B (1); Johnson, L (1); Rådegran, Göran (1); Solberg, O. G. (1); Akil, S (1); Hedeer, F (1); Hindorf, C (1); Sayed, S (1); Soriano, E (1); Lubberink, Mark (1); Martin, W (1); Yoshida, H (1); Fukuda, H. (1); show less...

University: Linköping University (2); Lund University (2); Karolinska Institutet (2); Uppsala University (1)

Language: English (7)

Research subject (UKÄ/SCB): Medical and Health Sciences (2)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view